X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (764) 764
Publication (29) 29
Book Chapter (11) 11
Book Review (8) 8
Conference Proceeding (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (371) 371
index medicus (305) 305
cardiac & cardiovascular systems (261) 261
clopidogrel (209) 209
male (202) 202
female (199) 199
middle aged (176) 176
aged (165) 165
ticlopidine - analogs & derivatives (149) 149
treatment outcome (137) 137
aspirin (129) 129
cardiovascular (124) 124
platelet aggregation inhibitors - therapeutic use (121) 121
percutaneous coronary intervention (114) 114
platelet aggregation inhibitors - administration & dosage (112) 112
acute coronary syndromes (100) 100
antiplatelet therapy (100) 100
thrombosis (99) 99
abridged index medicus (98) 98
coronary heart disease (97) 97
prasugrel (96) 96
peripheral vascular disease (91) 91
drug therapy (88) 88
cardiology (87) 87
blood platelets - drug effects (81) 81
risk factors (80) 80
prospective studies (79) 79
heart attacks (78) 78
hematology (78) 78
stents (78) 78
ticlopidine - therapeutic use (78) 78
care and treatment (76) 76
myocardial-infarction (74) 74
platelet aggregation inhibitors - adverse effects (72) 72
ticlopidine - administration & dosage (72) 72
internal medicine (70) 70
ticagrelor (70) 70
cardiac patients (66) 66
coronary artery disease - drug therapy (66) 66
acute coronary syndrome (65) 65
cardiovascular disease (63) 63
platelet function tests (62) 62
platelets (60) 60
blood platelets (59) 59
cardiology and cardiovascular medicine (57) 57
artery-disease (56) 56
diabetes mellitus (55) 55
time factors (55) 55
diabetes (53) 53
acute coronary syndrome - drug therapy (52) 52
platelet aggregation - drug effects (52) 52
aspirin - therapeutic use (51) 51
intervention (51) 51
coronary artery disease (48) 48
drug therapy, combination (48) 48
platelet reactivity (46) 46
stent (46) 46
platelet activation - drug effects (45) 45
drug-eluting stents (44) 44
medicine & public health (44) 44
coronary vessels (43) 43
double-blind method (43) 43
dual antiplatelet therapy (43) 43
elevation myocardial-infarction (43) 43
inhibition (42) 42
acute myocardial-infarction (40) 40
medical colleges (40) 40
prasugrel hydrochloride (40) 40
mortality (39) 39
risk (39) 39
blood platelets - metabolism (38) 38
dosage and administration (38) 38
ticlopidine - adverse effects (38) 38
transluminal angioplasty (38) 38
adenosine - analogs & derivatives (37) 37
adult (37) 37
angioplasty, balloon, coronary (36) 36
platelet aggregation inhibitors - pharmacology (36) 36
coronary artery disease - blood (35) 35
double-blind (35) 35
follow-up studies (35) 35
dose-response relationship, drug (34) 34
trial (34) 34
thrombosis - prevention & control (33) 33
aggregation (32) 32
clinical trials (32) 32
purinergic p2y receptor antagonists - administration & dosage (32) 32
research (32) 32
risk assessment (32) 32
stent thrombosis (32) 32
angioplasty (31) 31
platelet aggregation inhibitors - pharmacokinetics (31) 31
platelet function (31) 31
acute coronary syndrome - therapy (30) 30
cangrelor (30) 30
coronary angiography (30) 30
analysis (29) 29
association task-force (29) 29
bleeding (29) 29
platelet inhibition (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 12/2012, Volume 72, Issue 16, pp. 2087 - 2116
Our knowledge of the mechanisms of platelet-mediated thrombosis has increased dramatically over the last 40 years. This increased understanding has identified... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Cangrelor | ONO-3708 | Eptifibatide | Tirofiban | Vorapaxar | Sulotroban | Terutroban-sodium | Ramatroban | Ticagrelor | Atopaxar | Vapiprost | Aspirin | Abciximab | Pantoprazole | Picotamide | Thienopyridines | Cilostazol | Pharmacology | Z-335 | Egaptivon-pegol | Sarpogrelate | Ticlopidine | Omeprazole | Prasugrel | Elinogrel | Antiplatelets | Clopidogrel | Ifetroban | Pharmacokinetics | Acute-coronary-syndromes | MAINTENANCE-DOSE CLOPIDOGREL | GLYCOPROTEIN IIB/IIIA INHIBITORS | TIMI 38 TRIAL | RECURRENT CARDIOVASCULAR EVENTS | ASSOCIATION TASK-FORCE | PHARMACOLOGY & PHARMACY | TREATMENT PLATELET REACTIVITY | TOXICOLOGY | THROMBOTIC THROMBOCYTOPENIC PURPURA | P2Y RECEPTOR BLOCKADE | ELEVATION MYOCARDIAL-INFARCTION | ACCF/AHA FOCUSED UPDATE | Acute Coronary Syndrome - drug therapy | Purinergic P2Y Receptor Antagonists - pharmacology | Thienopyridines - pharmacokinetics | Thienopyridines - pharmacology | Humans | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Aspirin - pharmacokinetics | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation Inhibitors - pharmacokinetics | Aspirin - pharmacology | Blood Platelets - drug effects | Aggregation | Blood platelets | Patient outcomes | Dosage and administration | Diagnosis | Drug therapy | Coronary heart disease | Health aspects
Journal Article
The Lancet, ISSN 0140-6736, 10/2019, Volume 394, Issue 10206, pp. 1300 - 1302
Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) need oral anticoagulation to prevent cardioembolic events and... 
MEDICINE, GENERAL & INTERNAL | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Clinical trials | Thrombosis | Bleeding | Catheters | Genetic screening | Fibrillation | Inhibitors | Audio frequencies | Implants | Questions | Phylloquinone | Acute coronary syndromes | Thromboembolism | Factorial design | Biosensors | Vitamin K
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 09/2019, Volume 12, Issue 18, pp. 1868 - 1869
Journal Article
Giornale Italiano di Cardiologia, ISSN 1827-6806, 01/2012, Volume 13, Issue 1, pp. 1 - 4
Journal Article
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 801 - 802
Antithrombotic therapy plays a pivotal part in invasively managed patients with acute coronary syndrome, particularly in those who require percutaneous... 
BIVALIRUDIN | TRIAL | MEDICINE, GENERAL & INTERNAL | HEPARIN | PCI | Glycoproteins | Acute coronary syndromes | Biosensors | Thrombosis | Stents | Mortality
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 8, pp. 915 - 918
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2019, Volume 12, Issue 1, pp. 33 - 37
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2018, Volume 118, Issue 9, pp. 1509 - 1511
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 8, pp. 915 - 918
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2019, Volume 12, Issue 16, pp. 1577 - 1579
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2017, Volume 69, Issue 2, p. 250
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2017, Volume 69, Issue 2, pp. 250 - 251
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 09/2019, Volume 12, Issue 18, pp. 1868 - 1869
Journal Article
Circulation, ISSN 0009-7322, 10/2018, Volume 138, Issue 15, p. 1582
Byline: Laurent Bonello, Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hopital NORD, Aix-Marseille Universite, France (B.L.). MARS... 
Analysis | Adenosine diphosphate | Research | Kidney diseases | Acute coronary syndrome | Risk factors | Prevalence studies (Epidemiology)
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 09/2019, Volume 8, Issue 18
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.